Jonathan Dixon
Conseiller Juridique Général chez BIONANO GENOMICS, INC.
Fortune : 17 448 $ au 31/05/2024
Profil
Jonathan Dixon is currently working as the Secretary & General Counsel at Bionano Genomics, Inc. He previously worked as the Legal Director at GeneOhm Sciences, Inc., and as an Associate General Counsel at Becton, Dickinson & Co. and CareFusion Corp.
He completed his undergraduate degree at Brigham Young University and his graduate degree at Lewis & Clark Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIONANO GENOMICS, INC.
0,03% | 03/06/2024 | 18 025 ( 0,03% ) | 17 448 $ | 31/05/2024 |
Postes actifs de Jonathan Dixon
| Sociétés | Poste | Début |
|---|---|---|
| BIONANO GENOMICS, INC. | Conseiller Juridique Général | 01/03/2022 |
Anciens postes connus de Jonathan Dixon
| Sociétés | Poste | Fin |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
| CAREFUSION CORPORATION | Corporate Officer/Principal | - |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Directeur/Membre du Conseil | - |
Formation de Jonathan Dixon
| Brigham Young University | Undergraduate Degree |
| Lewis & Clark Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
CareFusion Corp.
 CareFusion Corp. Medical DistributorsDistribution Services CareFusion Corp. engages in the manufactures of medical equipment and device. The company was founded on February 4, 2009 and is headquartered in San Diego, CA. | Distribution Services |
